Genta Plans Genasense Confirmatory Trial In Treatment-Naive Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
With approval possible in June for relapsed or refractory leukemia, Genta is seeking a marketing partner for oblimersen.